David Koelle, MD, Infectious Disease, Seattle, WA, UW Medicine/Harborview Medical Center

DavidMKoelleMD

Infectious Disease Seattle, WA

Professor, Medicine, University of Washington School of Medicine

Dr. Koelle is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Koelle's full profile

Already have an account?

  • Office

    University of Washington
    750 Republican Street Room E651
    Seattle, WA 98109
    Phone(206) 616-1940
    Fax(206) 616-4898
  • Is this information wrong?

Education & Training

  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1985

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1988 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2004

Publications & Presentations

PubMed

Journal Articles

  • Varicella Zoster Virus Productively Infects Human Peripheral Blood Mononuclear Cells to Modulate Expression of Immunoinhibitory Proteins and Blocking PD-L1 Enhances Vi...  
    David M Koelle, Maria A Nagel, PLoS One
  • Viral Genetics Modulate Orolabial HSV-1 Shedding in Humans  
    Alex L Greninger, Eric Strachan, Keith R Jerome, David M Koelle, The Journal of Infectious Diseases
  • Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus-2 After Vaginal Inoculation of Rhesus Macaques  
    Jia Zhu, David Koelle, mBio
  • Join now to see all

Press Mentions

  • Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionFebruary 4th, 2021
  • Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses
    Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody ResponsesFebruary 4th, 2021
  • Study Predicts Good Passive Immunotherapy Donors to Combat COVID-19
    Study Predicts Good Passive Immunotherapy Donors to Combat COVID-19January 26th, 2021

Grant Support

  • Genomic Systems Approach To Measure Hsv-1-Specific T-Cell Dominance In HumansNational Institute Of Allergy And Infectious Diseases2012
  • Local Determinants Of HSV-2 Shedding In HumansNational Institute Of Allergy And Infectious Diseases2008–2011
  • Hsv-1-Specific T-Cell Responses In Human Sensory GangliaNational Institute Of Allergy And Infectious Diseases2009–2010
  • Vaccinia: T-Cell Immunity And Homing To SkinNational Institute Of Allergy And Infectious Diseases2006–2009
  • Immune Correlates Of HSV-2 Disease SeverityNational Institute Of Allergy And Infectious Diseases2003–2007
  • HSV Immunotherapeutic VaccineNational Institute Of Allergy And Infectious Diseases2005
  • Intradermal Vaccinia:T-Cell Specificity And Skin HomingNational Institute Of Allergy And Infectious Diseases2004–2005
  • Mucosal T Cell Responses To HSV InfectionsNational Institute Of Allergy And Infectious Diseases1998–2002
  • Immune Correlates Of HSV-2 Disease SeverityNational Institute Of Allergy And Infectious Diseases2001
  • Lesion T Cell Response To HSV In HIV InfectionNational Cancer Institute1997–1999
  • Lesion CD4 T Cell Response To Human Genital HerpesNational Institute Of Allergy And Infectious Diseases1996–1998
  • Lesion T Cell Response To HSV In HIV InfectionNational Cancer Institute1995–1996

Hospital Affiliations